Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Blood|May 7, 2025
Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCTCindy Sheree Flamann, Haroon Shaikh, Carina Matos, et al.
European Journal of Immunology|August 5, 2021
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunityAndreas E Kremer, Anita N Kremer, Carsten Willam, et al.
Blood|June 12, 2025
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphomaFabian Müller, Nora Rebecca Schwingen, Melanie Hagen, et al.
Nature Medicine|September 15, 2022
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosusAndreas Mackensen, Fabian Müller, Dimitrios Mougiakakos, et al.
Ebiomedicine|August 4, 2020
Vascular occlusion by neutrophil extracellular traps in COVID-19Moritz Leppkes, Jasmin Knopf, Elisabeth Naschberger, et al.
EJNMMI Research|March 17, 2025
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphomaMichael Beck, Viktoria Blumenberg, Veit L Bücklein, et al.
Cancer Immunology Research|February 10, 2021
The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated MacrophagesDimitrios Mougiakakos, Christian Bach, Martin Böttcher, et al.
Immunity|July 21, 2021
β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progressionDaniel Hofbauer, Dimitrios Mougiakakos, Luca Broggini, et al.
Blood|June 5, 2014
Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiencyAnne Rensing-Ehl, Simon Völkl, Carsten Speckmann, et al.
The Lancet. Rheumatology|May 3, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational studyMelanie Hagen, Fabian Müller, Andreas Wirsching, et al.
Pageof 7